CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

/ 5
Filters:
Show search box
2012-04-23
BioForum 2012. The most important meeting for biotechnology industry of Central Europe.

BioForum 2012. The most important meeting for biotechnology industry of Central Europe.

On May 23rd-24th the biggest and the most important meeting for biotechnology industry of Central Europe will be held in Brno in Czech Republic. The event is meant to gather scientists, businessmen, journalists, students and all those who are simply interested in this matter. The representatives of t... Read more
Tags bioforum , biotechnology
2012-04-02
Emerging Regenerative Medicine Firm in Czech Republic Chooses CellBase CT

Emerging Regenerative Medicine Firm in Czech Republic Chooses CellBase CT

To Improve Reproducibility and Affordability of their Autologous Cell Therapies... Read more
Tags biotechnology , czech republic , medicine
2012-03-05
Inno-Gene competes in the American market

Inno-Gene competes in the American market

CB DNA and NewLab Systems, co-partnerships of Inno-Gene Ltd., have recently signed an agreement with an American company, Caliper Life Sciences, Hopkinton-Massachusetts, concerning distribution of innovative laboratory systems in the Polish market.... Read more
Tags biotechnology , poland
2012-02-20 to 2012-02-24
Biotechnological drug Prolia® rewarded as the Innovation for Health 2011

Biotechnological drug Prolia® rewarded as the Innovation for Health 2011

On January 2012 the Innovation for Health contest was completed. Drug companies, patient associations, drugs, hospitals and foundations could have been rewarded in one of the following categories: prophylaxis, education and promotion of patient activity, management, medical technologies and equipment... Read more
Tags biotechnology , poland , pharma
Mabion achieves a record income

Mabion achieves a record income

Polish company, Mabion co., obtained over 4.1 mio PLN (1 mio EUR) sales income in the 4th quarter of 2011. After four quarters sales of the company was increasingly accounting for 10.5 mio PLN (2.5 mio EUR). It is over 7.4 mio PLN (1.8 mio EUR) more than after 2010.... Read more
Tags biotechnology , poland
Stem Cells Spin co. obtained two new patents and enters the market with first products!

Stem Cells Spin co. obtained two new patents and enters the market with first products!

Stem Cells Spin co., a company from Wroclaw, Poland, is confidently approaching success in realization of its business plans. The company has recently obtained two new patents, which strengthen its position while entering the market with products of unique characteristics.... Read more
Tags biotechnology , poland
2012-02-15 to 2012-02-16
How to market your biotech company?

How to market your biotech company?

Biotech scientists are full of ideas. Some ideas are fanciful and never tested. Some ideas are tested and fail the tests. Others are tested and found to be worthy of implementation and commercialization. How are ideas created? How are ideas tested and implemented? How do ideas contribute to scientifi... Read more
Tags bioforum , biotechnology
BioMaxima confirms its strong position in business

BioMaxima confirms its strong position in business

Quoted BioMaxima co. consequently strengthens its leading position within Polish biotechnology companies. Enormous profits turned by the company in the 4th quarter of 2011 clearly indicate its dynamic development.... Read more
Tags biotechnology , poland
2012-01-29
Selvita 1st in Deloitte Technology Fast 50 Central Europe 2011

Selvita 1st in Deloitte Technology Fast 50 Central Europe 2011

“We would like to become one of the globally recognised drug discovery service providers, achieving a stable increase in revenues and profits from services rendered to pharmaceutical companies and R&D laboratories” - says Paweł Przewięźlikowski, CEO... Read more
Tags bioforum , biotechnology , poland
2012-01-09
“There is no success without defeat” – how to win in a high risk biotech enterprise

“There is no success without defeat” – how to win in a high risk biotech enterprise

Central Europe (CE) is an emerging biotech market, a small star among European regions. There are more or less 200 innovative biotechcompanies, which mostly were established in last 10 years. During the 11th edition of BioForum, Central European Forum of Biotechnology and Innovative BioEconomy, held ... Read more
Tags bioforum , biotechnology